| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/15/2003 | US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles |
| 04/15/2003 | US6548293 Enzymatic process for the resolution of enantiomeric mixtures of β-lactams |
| 04/15/2003 | CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| 04/15/2003 | CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/11/2003 | WO2002034724A1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses |
| 04/10/2003 | WO2003029247A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | WO2003029241A1 Chk1 kinase inhibitors |
| 04/10/2003 | WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029223A1 Substituted n-(1,4,5,6-tetrahydrocyclopentapyrazol-3-yl) derivatives and the use of the same for the treatment of cancer |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028727A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 04/10/2003 | WO2003028725A1 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands |
| 04/10/2003 | WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028719A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 04/10/2003 | WO2003028652A2 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| 04/10/2003 | WO2003028641A2 Mch receptor antagonists |
| 04/10/2003 | WO2003028459A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 04/10/2003 | WO2003028458A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 04/10/2003 | WO2003007069A3 Novel nonlinear optical polymers |
| 04/10/2003 | WO2003004493A8 Novel compounds, their preparation and use |
| 04/10/2003 | WO2003004486A3 Process for preparing isocoumarins |
| 04/10/2003 | WO2002102978A3 Human growth hormone antagonists |
| 04/10/2003 | WO2002102793A3 Quinazolinediones as antibacterial agents |
| 04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2003 | WO2002078639A3 A method of treating proliferative diseases using eg5 inhibitors |
| 04/10/2003 | WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/10/2003 | US20030069284 Anticancer agent |
| 04/10/2003 | US20030069278 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | US20030069276 Viricides; aids therapy |
| 04/10/2003 | US20030069267 Modulators of protein tyrosine phosphatases (PTPases) |
| 04/10/2003 | US20030069257 Benzimidazole and pyridylimidazole derivatives |
| 04/10/2003 | US20030069252 Viricides; antiinflammatory agents |
| 04/10/2003 | US20030069245 Aids therapy |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
| 04/10/2003 | US20030069224 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069140 Herbicides |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462594A1 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| 04/10/2003 | CA2462419A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | CA2462030A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 04/10/2003 | CA2461919A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 04/10/2003 | CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/10/2003 | CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/09/2003 | EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 04/09/2003 | EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 04/09/2003 | EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors |
| 04/09/2003 | EP1299379A2 Lactam metalloprotease inhibitors |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 04/09/2003 | EP1299356A1 Novel compounds |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1198453B1 N-(indolcarbonyl-)piperazin derivatives |
| 04/09/2003 | EP1178985B1 Substituted thienocycloalk(en)ylamino-1,3,5-triazine |
| 04/09/2003 | EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 04/09/2003 | EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
| 04/09/2003 | EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/09/2003 | EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/09/2003 | EP0873123B1 Inhibitors of protein isoprenyl transferases |
| 04/09/2003 | EP0850224B1 Radiation-activated cytotoxin therapy |
| 04/09/2003 | EP0758327B1 Pyranone compounds useful to treat retroviral infections |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409703A 4-aminopiperidine derivatives and their use as medicine |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105113C Fungicidal pyrimidinones |
| 04/08/2003 | US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 04/08/2003 | US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6544993 Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
| 04/08/2003 | US6544984 2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544976 Treating disorders characterized by neuronal damage caused by disease or trauma, such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and Bell's palsy. |
| 04/08/2003 | US6544970 Administering in a first phase of a progestational agent (levonorgestrel or ethinylestradiol) and in a second phase an antiprogestin that is an indolinone derivative, especially a 3-spiroalkylene derivative |
| 04/08/2003 | CA2123548C Piperazine derivatives |
| 04/08/2003 | CA2097824C Functionalized vinyl azoles and their use |
| 04/08/2003 | CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027234A2 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | WO2003027109A1 3-(heteroarylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027085A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |